Related Experiment Video
Updated: Aug 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
A knowledge-enhanced domain-aware large language model agent for atrial fibrillation management
Yijun Wang1,2, Chen Peng3, Ruijie Hu3
1Department of Cardiology; The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
A new system called PULSE enhances large language models (LLMs) for atrial fibrillation (AF) self-management. It improves accuracy and readability, boosting patient care and outcomes.
Area of Science:
- Artificial Intelligence in Medicine
- Digital Health
- Chronic Disease Management
Background:
- Large language models (LLMs) offer potential for atrial fibrillation (AF) management but face accuracy challenges.
- Current clinical LLM applications often yield suboptimal results for patient self-management.
Purpose of the Study:
- To develop PULSE, a novel knowledge-enhanced, domain-aware LLM agent for improved AF patient self-management.
- To enhance the accuracy, utility, safety, and readability of LLM-generated medical information for patients.
Main Methods:
- Integrated multimodal inputs, curated clinical knowledge bases, prompt engineering, and retrieval-augmented generation.
- Developed an agent-based architecture for the LLM.
- Evaluated performance against four base LLMs on response quality and readability.
Main Results:
- PULSE significantly improved clinical accuracy, content integrity, utility, and safety (P < 0.05).
- Enhanced empathy and clarity in patient-facing outputs.
- Maintained comparable conciseness to existing models.
Conclusions:
- PULSE demonstrates significant potential for advancing chronic disease self-management through improved LLM performance.
- Agent-driven LLM systems can enhance both factual accuracy and readability of medical information.
- Improved patient self-management can lead to better long-term health outcomes.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure V: Medical Management
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
